
Why investors just bet $85M on this Indian company’s generic drug strategy
India is one of the world’s largest medicine markets, with over 400 million chronic patients. While most e-pharmacies prioritize speed, affordability remains the real challenge. Truemeds took a different approach by helping patients switch to lower-cost substitutes, a strategy that…









